Skip to content

Compressive Device to Prevent Keloïd Scars Recurrence [SCARWARS]

First Study Evaluating Efficiency and Safety of a Compressive Device to Prevent Keloid Scars Recurrence After Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03312166
Acronym
SCARWARS
Enrollment
31
Registered
2017-10-17
Start date
2017-10-03
Completion date
2023-12-14
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keloid

Keywords

ear lobe, compression, medical device, recurrence

Brief summary

SCARWARS study deals with the first on-human evaluation of a compressive device dedicated to the prevention of keloïd scars recurrence after surgery. The tested device is made with clinical grade silicon. SCARWARS is a monocentric study. 27 patients will be include and follow during one year. The primary outcome of this study is the number of keloid recurrence after treatment.

Interventions

interventions on patient are : * surgical excision of ear lobe keloid * application of compression device on sutured skin

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient over 18 yo; * Patient with aer lobe keloid; * Patient with an indication of reconstructive surgery; * Signature of informed consent from the patient; * Indication that the subject has understood the purpose and procedures required by the study and agrees to participate in the study and comply with the requirements and limitations inherent in this study; * Patient with French social insurance.

Exclusion criteria

* Patient with cutaneous dermatosis or other skin pathology able to interfere with evaluated parameter (recurrence and healing quality); * Patient with know nickel allergy; * Patient with know silicon allergy; * Pregnant women; * Legal incapacity or limited legal capacity; * Patient unlikely to cooperate in the study and / or low cooperation anticipated by the investigator; * Patient without health insurance; * The patient is in the period of exclusion of another study.

Design outcomes

Primary

MeasureTime frameDescription
Recurrence of keloid scar12 monthRecurrence will be assessed during each visit by surgeon

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026